Investment Highlights

Telo Genomics provides important actionable information to medical professionals in the management of cancer or cognitive disease. It applies innovative, minimally-invasive analysis of genomic instability based on the three-dimensional organization of telomeres for the purpose of reducing treatment cost and improving quality of life.

The company targets unmet clinical needs. Its lead application for Multiple Myeloma addresses a critical area where current blood tests are incapable of identifying early onset of disease and patient relapse.

Hugh Rogers

Email: info@telodx.com
Ph: 416-673-8487

Contact Us

info@telodx.com

Ph : 416-673-8487

Address

MaRS Centre, South Tower
101 College Street, Suite 200
Toronto, Ontario
Canada M5G 1L7

Contact Us

info@telodx.com
Ph : 416-673-8487

Address

MaRS Centre, South Tower
101 College Street, Suite 200
Toronto, Ontario
Canada M5G 1L7

(c) 2020 Telo Genomics . All rights reserved.

Website Designed & Maintained By :: WebStudio.ca